Difference between revisions of "FEMA5:Volunteer Assignments and Opportunities"
Jump to navigation
Jump to search
[checked revision] | [checked revision] |
(Created page with "Welcome! For assignments, please see the "Author" column below (highlighted blue). If empty (no name is present), please volunteer to create content for that disease! To vo...") |
|||
(10 intermediate revisions by the same user not shown) | |||
Line 17: | Line 17: | ||
!'''Notes''' | !'''Notes''' | ||
|- | |- | ||
+ | |CHAPTER 2 (TUMOURS OF THE OVARY) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | |- | ||
+ | |[[FEMA5:Serous_cystadenoma,_adenofibroma,_and_surface_papilloma_of_the_ovary|Serous cystadenoma, adenofibroma, and surface papilloma of the ovary]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Serous_borderline_tumour_of_the_ovary|Serous borderline tumour of the ovary]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Low-grade_serous_carcinoma_of_the_ovary|Low-grade serous carcinoma of the ovary]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:High-grade_serous_carcinoma_of_the_ovary|High-grade serous carcinoma of the ovary]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Mucinous_cystadenoma_and_adenofibroma|Mucinous cystadenoma and adenofibroma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Mucinous_borderline_tumour_|Mucinous borderline tumour]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Mucinous_carcinoma_of_the_ovary|Mucinous carcinoma of the ovary]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Endometrioid_cystadenoma_and_adenofibroma|Endometrioid cystadenoma and adenofibroma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Endometrioid_borderline_tumour|Endometrioid borderline tumour]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Endometrioid_carcinoma_of_the_ovary|Endometrioid carcinoma of the ovary]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Clear_cell_cystadenoma_and_adenofibroma|Clear cell cystadenoma and adenofibroma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Clear_cell_borderline_tumour|Clear cell borderline tumour]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Clear_cell_carcinoma_of_the_ovary|Clear cell carcinoma of the ovary]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Seromucinous_cystadenoma_and_adenofibroma|Seromucinous cystadenoma and adenofibroma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Seromucinous_borderline_tumour|Seromucinous borderline tumour]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Brenner_tumour_|Brenner tumour]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Borderline_Brenner_tumour|Borderline Brenner tumour]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Malignant_Brenner_tumour_|Malignant Brenner tumour]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Mesonephric-like_adenocarcinoma|Mesonephric-like adenocarcinoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Undifferentiated_and_dedifferentiated_carcinomas_of_the_ovary|Undifferentiated and dedifferentiated carcinomas of the ovary]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Carcinosarcoma_of_the_ovary|Carcinosarcoma of the ovary]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Mixed_carcinoma_of_the_ovary|Mixed carcinoma of the ovary]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Endometrioid_stromal_sarcoma_of_the_ovary|Endometrioid stromal sarcoma of the ovary]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Smooth_muscle_tumours_of_the_ovary|Smooth muscle tumours of the ovary]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Ovarian_myxoma_|Ovarian myxoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Adenosarcoma_of_the_ovary|Adenosarcoma of the ovary]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Ovarian_fibroma_|Ovarian fibroma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Thecoma_|Thecoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Luteinized_thecoma_associated_with_sclerosing_peritonitis_|Luteinized thecoma associated with sclerosing peritonitis]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Sclerosing_stromal_tumour_|Sclerosing stromal tumour]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Microcystic_stromal_tumour_|Microcystic stromal tumour]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Signet-ring_stromal_tumour_|Signet-ring stromal tumour]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Leydig_cell_tumour_|Leydig cell tumour]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Steroid_cell_tumour_|Steroid cell tumour]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Ovarian_fibrosarcoma_|Ovarian fibrosarcoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Adult_granulosa_cell_tumour_|Adult granulosa cell tumour]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Juvenile_granulosa_cell_tumour_|Juvenile granulosa cell tumour]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Sertoli_cell_tumour_|Sertoli cell tumour]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Sex_cord_tumour_with_annular_tubules_|Sex cord tumour with annular tubules]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Sertoli-Leydig_cell_tumour|Sertoli-Leydig cell tumour]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Sex_cord-stromal_tumour_NOS|Sex cord-stromal tumour NOS]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Gynandroblastoma|Gynandroblastoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Mature_teratoma_of_the_ovary|Mature teratoma of the ovary]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Immature_teratoma_of_the_ovary|Immature teratoma of the ovary]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Dysgerminoma_|Dysgerminoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Yolk_sac_tumour_|Yolk sac tumour]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Embryonal_carcinoma_|Embryonal carcinoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Non-gestational_choriocarcinoma_|Non-gestational choriocarcinoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Mixed_germ_cell_tumour_of_the_ovary|Mixed germ cell tumour of the ovary]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Struma_ovarii_|Struma ovarii]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Ovarian_carcinoid|Ovarian carcinoid]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Neuroectodermal-type_tumours|Neuroectodermal-type tumours]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Monodermal_cystic_teratoma_|Monodermal cystic teratoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Somatic_neoplasms_arising_from_teratomas|Somatic neoplasms arising from teratomas]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Gonadoblastoma|Gonadoblastoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Mixed_germ_cell-sex_cord-stromal_tumour,_unclassified|Mixed germ cell-sex cord-stromal tumour, unclassified]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Rete_cystadenoma,_adenoma,_and_adenocarcinoma|Rete cystadenoma, adenoma, and adenocarcinoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Wolffian_tumour_of_the_ovary|Wolffian tumour of the ovary]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Solid_pseudopapillary_tumour_|Solid pseudopapillary tumour]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Small_cell_carcinoma_of_the_ovary,_hypercalcaemic_type|Small cell carcinoma of the ovary, hypercalcaemic type]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Wilms_tumour_|Wilms tumour]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Follicle_cyst|Follicle cyst]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Corpus_luteum_cyst|Corpus luteum cyst]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Large_solitary_luteinized_follicle_cyst|Large solitary luteinized follicle cyst]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Hyperreactio_luteinalis|Hyperreactio luteinalis]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Pregnancy_luteoma|Pregnancy luteoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Stromal_hyperplasia_and_hyperthecosis|Stromal hyperplasia and hyperthecosis]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Fibromatosis_and_massive_oedema|Fibromatosis and massive oedema]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Leydig_cell_hyperplasia|Leydig cell hyperplasia]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Metastases_to_the_ovary|Metastases to the ovary]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |CHAPTER 3 (ENDOMETRIOSIS AND RELATED CONDITIONS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | |- | ||
+ | |[[FEMA5:Endometriosis_and_derived_tumours|Endometriosis and derived tumours]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |CHAPTER 4 (TUMOURS OF THE PERITONEUM) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | |- | ||
+ | |[[FEMA5:Adenomatoid_tumour_|Adenomatoid tumour]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Well-differentiated_papillary_mesothelial_tumour_|Well-differentiated papillary mesothelial tumour]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:_Mesothelioma_| Mesothelioma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Serous_borderline_tumour_of_the_peritoneum|Serous borderline tumour of the peritoneum]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Low-grade_serous_carcinoma_of_the_peritoneum|Low-grade serous carcinoma of the peritoneum]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:High-grade_serous_carcinoma_of_the_peritoneum|High-grade serous carcinoma of the peritoneum]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:_Leiomyomatosis_peritonealis_disseminata_| Leiomyomatosis peritonealis disseminata]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Desmoid_fibromatosis|Desmoid fibromatosis]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Calcifying_fibrous_tumour_|Calcifying fibrous tumour]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Extragastrointestinal_stromal_tumour|Extragastrointestinal stromal tumour]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Solitary_fibrous_tumour_of_the_peritoneum|Solitary fibrous tumour of the peritoneum]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Endometrioid_stromal_sarcoma_of_the_peritoneum|Endometrioid stromal sarcoma of the peritoneum]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Mesothelial_hyperplasia|Mesothelial hyperplasia]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Peritoneal_inclusion_cysts_|Peritoneal inclusion cysts]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Transitional_cell_metaplasia|Transitional cell metaplasia]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Endosalpingiosis_of_the_peritoneum|Endosalpingiosis of the peritoneum]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Histiocytic_nodule|Histiocytic nodule]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Ectopic_decidua|Ectopic decidua]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Splenosis|Splenosis]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Other_tumour-like_lesions_of_the_peritoneum|Other tumour-like lesions of the peritoneum]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Carcinomas_and_sarcomas_metastatic_to_the_peritoneum|Carcinomas and sarcomas metastatic to the peritoneum]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Pseudomyxoma_peritonei|Pseudomyxoma peritonei]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Gliomatosis|Gliomatosis]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |CHAPTER 5 (TUMOURS OF THE FALLOPIAN TUBE) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | |- | ||
+ | |[[FEMA5:Serous_adenofibroma_and_papilloma_of_the_fallopian_tube|Serous adenofibroma and papilloma of the fallopian tube]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Serous_borderline_tumour_of_the_fallopian_tube|Serous borderline tumour of the fallopian tube]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:High-grade_serous_carcinoma_of_the_fallopian_tube|High-grade serous carcinoma of the fallopian tube]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Endometrioid_carcinoma_of_the_fallopian_tube|Endometrioid carcinoma of the fallopian tube]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Carcinosarcoma_of_the_fallopian_tube|Carcinosarcoma of the fallopian tube]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Paratubal_cysts|Paratubal cysts]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Tubal_hyperplasia|Tubal hyperplasia]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Tubo-ovarian_abscess|Tubo-ovarian abscess]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Salpingitis_isthmica_nodosa|Salpingitis isthmica nodosa]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Metaplastic_papillary_lesion|Metaplastic papillary lesion]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Placental_site_nodule_occurring_in_the_fallopian_tube|Placental site nodule occurring in the fallopian tube]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Mucinous_metaplasia|Mucinous metaplasia]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Adenosarcoma_of_the_fallopian_tube|Adenosarcoma of the fallopian tube]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Teratoma_of_the_fallopian_tube|Teratoma of the fallopian tube]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |CHAPTER 6 (TUMOURS OF THE BROAD LIGAMENT AND OTHER UTERINE LIGAMENTS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | |- | ||
+ | |[[FEMA5:Leiomyoma_of_the_broad_ligament_and_other_uterine_ligaments|Leiomyoma of the broad ligament and other uterine ligaments]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Adenomyoma_of_the_broad_ligament_and_other_uterine_ligaments|Adenomyoma of the broad ligament and other uterine ligaments]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Adenosarcoma_of_the_broad_ligament_and_other_uterine_ligaments|Adenosarcoma of the broad ligament and other uterine ligaments]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Leiomyosarcoma_of_the_broad_ligament_and_other_uterine_ligaments|Leiomyosarcoma of the broad ligament and other uterine ligaments]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Wolffian_tumour_of_the_broad_ligament_and_other_uterine_ligaments|Wolffian tumour of the broad ligament and other uterine ligaments]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Papillary_cystadenoma_|Papillary cystadenoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Ependymoma_|Ependymoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Adrenocortical_remnants|Adrenocortical remnants]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |CHAPTER 7 (TUMOURS OF THE UTERINE CORPUS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | |- | ||
+ | |[[FEMA5:Endometrial_hyperplasia_without_atypia|Endometrial hyperplasia without atypia]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Endometrial_atypical_hyperplasia_/_endometrioid_intraepithelial_neoplasia|Endometrial atypical hyperplasia / endometrioid intraepithelial neoplasia]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Endometrioid_carcinoma_of_the_uterine_corpus|Endometrioid carcinoma of the uterine corpus]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Serous_carcinoma_of_the_uterine_corpus|Serous carcinoma of the uterine corpus]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 27: | Line 1,468: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Clear_cell_carcinoma_of_the_uterine_corpus_|Clear cell carcinoma of the uterine corpus]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 36: | Line 1,479: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Undifferentiated_and_dedifferentiated_carcinomas_of_the_uterine_corpus|Undifferentiated and dedifferentiated carcinomas of the uterine corpus]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 45: | Line 1,490: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Mixed_carcinoma_of_the_uterine_corpus|Mixed carcinoma of the uterine corpus]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 54: | Line 1,501: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Other_endometrial_carcinomas|Other endometrial carcinomas]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 63: | Line 1,512: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Carcinosarcoma_of_the_uterine_corpus|Carcinosarcoma of the uterine corpus]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 72: | Line 1,523: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Endometrial_polyp|Endometrial polyp]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 81: | Line 1,534: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Endometrial_metaplasia|Endometrial metaplasia]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 90: | Line 1,545: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Arias-Stella_reaction_of_the_uterine_corpus|Arias-Stella reaction of the uterine corpus]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 99: | Line 1,556: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Uterine_leiomyoma|Uterine leiomyoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 108: | Line 1,567: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Intravenous_leiomyomatosis_|Intravenous leiomyomatosis]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 117: | Line 1,578: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Smooth_muscle_tumour_of_uncertain_malignant_potential_of_the_uterine_corpus|Smooth muscle tumour of uncertain malignant potential of the uterine corpus]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 126: | Line 1,589: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Metastasizing_leiomyoma_|Metastasizing leiomyoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 135: | Line 1,600: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Uterine_leiomyosarcoma_|Uterine leiomyosarcoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 144: | Line 1,611: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Endometrial_stromal_nodule_|Endometrial stromal nodule]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 153: | Line 1,622: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Low-grade_endometrial_stromal_sarcoma_|Low-grade endometrial stromal sarcoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 162: | Line 1,633: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:High-grade_endometrial_stromal_sarcoma_|High-grade endometrial stromal sarcoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 171: | Line 1,644: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Undifferentiated_uterine_sarcoma_|Undifferentiated uterine sarcoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 180: | Line 1,655: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Uterine_tumour_resembling_ovarian_sex_cord_tumour_|Uterine tumour resembling ovarian sex cord tumour]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 189: | Line 1,666: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Perivascular_epithelioid_cell_tumour_(PEComa)|Perivascular epithelioid cell tumour (PEComa)]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 198: | Line 1,677: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 207: | Line 1,688: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Adenomyoma_of_the_uterine_corpus|Adenomyoma of the uterine corpus]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 216: | Line 1,699: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Atypical_polypoid_adenomyoma_|Atypical polypoid adenomyoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 225: | Line 1,710: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Adenosarcoma_of_the_uterine_corpus|Adenosarcoma of the uterine corpus]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 234: | Line 1,721: | ||
| | | | ||
|- | |- | ||
− | | ||Disease|| | + | |[[FEMA5:Central_primitive_neuroectodermal_tumour_/_CNS_embryonal_tumour|Central primitive neuroectodermal tumour / CNS embryonal tumour]] |
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Germ_cell_tumours_of_the_uterine_corpus|Germ cell tumours of the uterine corpus]] | ||
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 243: | Line 1,743: | ||
| | | | ||
|- | |- | ||
− | | || | + | |CHAPTER 8 (GESTATIONAL TROPHOBLASTIC DISEASE) |
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
|- | |- | ||
− | | ||Disease|| | + | |[[FEMA5:Exaggerated_placental_site_reaction|Exaggerated placental site reaction]] |
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Placental_site_nodule_and_plaque|Placental site nodule and plaque]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Abnormal_(non-molar)_villous_lesions|Abnormal (non-molar) villous lesions]] | ||
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 261: | Line 1,796: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Partial_hydatidiform_mole|Partial hydatidiform mole]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 270: | Line 1,807: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Complete_hydatidiform_mole|Complete hydatidiform mole]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 279: | Line 1,818: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Invasive_and_metastatic_hydatidiform_moles|Invasive and metastatic hydatidiform moles]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 288: | Line 1,829: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Epithelioid_trophoblastic_tumour_|Epithelioid trophoblastic tumour]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 297: | Line 1,840: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Placental_site_trophoblastic_tumour_|Placental site trophoblastic tumour]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 306: | Line 1,851: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Gestational_choriocarcinoma|Gestational choriocarcinoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 315: | Line 1,862: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Mixed_trophoblastic_tumour|Mixed trophoblastic tumour]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 324: | Line 1,873: | ||
| | | | ||
|- | |- | ||
− | | || | + | |CHAPTER 9 (TUMOURS OF THE UTERINE CERVIX) |
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Squamous_metaplasia|Squamous metaplasia]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 342: | Line 1,904: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Atrophy_of_the_uterine_cervix|Atrophy of the uterine cervix]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 351: | Line 1,915: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Squamous_intraepithelial_lesions_of_the_uterine_cervix|Squamous intraepithelial lesions of the uterine cervix]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 360: | Line 1,926: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Squamous_cell_carcinoma,_HPV-associated,_of_the_uterine_cervix|Squamous cell carcinoma, HPV-associated, of the uterine cervix]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 369: | Line 1,937: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Squamous_cell_carcinoma,_HPV-independent,_of_the_uterine_cervix|Squamous cell carcinoma, HPV-independent, of the uterine cervix]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 378: | Line 1,948: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Endocervical_polyp|Endocervical polyp]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 387: | Line 1,959: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Mullerian_papilloma_of_the_uterine_cervix|Mullerian papilloma of the uterine cervix]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 396: | Line 1,970: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Nabothian_cyst|Nabothian cyst]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 405: | Line 1,981: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Tunnel_clusters|Tunnel clusters]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 414: | Line 1,992: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Microglandular_hyperplasia|Microglandular hyperplasia]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 423: | Line 2,003: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Lobular_endocervical_glandular_hyperplasia|Lobular endocervical glandular hyperplasia]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 432: | Line 2,014: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Diffuse_laminar_endocervical_hyperplasia|Diffuse laminar endocervical hyperplasia]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 441: | Line 2,025: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Mesonephric_remnants_and_hyperplasia|Mesonephric remnants and hyperplasia]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 450: | Line 2,036: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Arias-Stella_reaction_of_the_uterine_cervix|Arias-Stella reaction of the uterine cervix]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 459: | Line 2,047: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Endocervicosis_of_the_uterine_cervix|Endocervicosis of the uterine cervix]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 468: | Line 2,058: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Tuboendometrioid_metaplasia|Tuboendometrioid metaplasia]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 477: | Line 2,069: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Ectopic_prostate_tissue|Ectopic prostate tissue]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 486: | Line 2,080: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Adenocarcinoma_in_situ,_HPV-associated,_of_the_uterine_cervix|Adenocarcinoma in situ, HPV-associated, of the uterine cervix]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 495: | Line 2,091: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Adenocarcinoma,_HPV-associated,_of_the_uterine_cervix|Adenocarcinoma, HPV-associated, of the uterine cervix]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 504: | Line 2,102: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Adenocarcinoma_in_situ,_HPV-independent,_of_the_uterine_cervix|Adenocarcinoma in situ, HPV-independent, of the uterine cervix]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 513: | Line 2,113: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Adenocarcinoma,_HPV-independent,_gastric_type,_of_the_uterine_cervix|Adenocarcinoma, HPV-independent, gastric type, of the uterine cervix]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 522: | Line 2,124: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Adenocarcinoma,_HPV-independent,_clear_cell_type,_of_the_uterine_cervix|Adenocarcinoma, HPV-independent, clear cell type, of the uterine cervix]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 531: | Line 2,135: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Adenocarcinoma,_HPV-independent,_mesonephric_type,_of_the_uterine_cervix|Adenocarcinoma, HPV-independent, mesonephric type, of the uterine cervix]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 540: | Line 2,146: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Other_adenocarcinomas_of_the_uterine_cervix|Other adenocarcinomas of the uterine cervix]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 549: | Line 2,157: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Carcinosarcoma_of_the_uterine_cervix|Carcinosarcoma of the uterine cervix]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 558: | Line 2,168: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Adenosquamous_and_mucoepidermoid_carcinomas_of_the_uterine_cervix|Adenosquamous and mucoepidermoid carcinomas of the uterine cervix]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 567: | Line 2,179: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Adenoid_basal_carcinoma_of_the_uterine_cervix|Adenoid basal carcinoma of the uterine cervix]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 576: | Line 2,190: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Carcinoma_of_the_uterine_cervix,_unclassifiable|Carcinoma of the uterine cervix, unclassifiable]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 585: | Line 2,201: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Adenomyoma_of_the_uterine_cervix|Adenomyoma of the uterine cervix]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 594: | Line 2,212: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Adenosarcoma_of_the_uterine_cervix|Adenosarcoma of the uterine cervix]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 603: | Line 2,223: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Germ_cell_tumours_of_the_uterine_cervix|Germ cell tumours of the uterine cervix]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 612: | Line 2,234: | ||
| | | | ||
|- | |- | ||
− | | || | + | |CHAPTER 10 (TUMOURS OF THE VAGINA) |
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
| | | | ||
+ | ---- | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Squamous_papilloma_of_the_vagina|Squamous papilloma of the vagina]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 630: | Line 2,265: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Atrophy_of_the_vagina|Atrophy of the vagina]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 639: | Line 2,276: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Tubulosquamous_polyp_|Tubulosquamous polyp]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 648: | Line 2,287: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Squamous_intraepithelial_lesions_of_the_vagina|Squamous intraepithelial lesions of the vagina]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 657: | Line 2,298: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Squamous_cell_carcinoma,_HPV-associated,_of_the_vagina|Squamous cell carcinoma, HPV-associated, of the vagina]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 666: | Line 2,309: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Squamous_cell_carcinoma,_HPV-independent,_of_the_vagina|Squamous cell carcinoma, HPV-independent, of the vagina]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 675: | Line 2,320: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Villous_adenoma_|Villous adenoma]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 684: | Line 2,331: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Mullerian_papilloma_of_the_vagina|Mullerian papilloma of the vagina]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 693: | Line 2,342: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Vaginal_adenosis|Vaginal adenosis]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 702: | Line 2,353: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Endocervicosis_of_the_vagina|Endocervicosis of the vagina]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 711: | Line 2,364: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Cysts_of_the_vagina|Cysts of the vagina]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 720: | Line 2,375: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Adenocarcinoma,_HPV-associated,_of_the_vagina|Adenocarcinoma, HPV-associated, of the vagina]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 729: | Line 2,386: | ||
| | | | ||
|- | |- | ||
− | | ||Disease | + | |[[FEMA5:Endometrioid_carcinoma_of_the_vagina|Endometrioid carcinoma of the vagina]] |
+ | |Disease | ||
+ | | | ||
| | | | ||
| | | | ||
Line 738: | Line 2,397: | ||
| | | | ||
|- | |- | ||
+ | |[[FEMA5:Clear_cell_carcinoma_of_the_vagina|Clear cell carcinoma of the vagina]] | ||
+ | |Disease | ||
| | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Mucinous_carcinoma,_gastric_type,_of_the_vagina|Mucinous carcinoma, gastric type, of the vagina]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Mucinous_carcinoma,_intestinal_type,_of_the_vagina|Mucinous carcinoma, intestinal type, of the vagina]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Mesonephric_adenocarcinoma_of_the_vagina|Mesonephric adenocarcinoma of the vagina]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Carcinosarcoma_of_the_vagina|Carcinosarcoma of the vagina]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Mixed_tumour_of_the_vagina|Mixed tumour of the vagina]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Adenocarcinoma_of_Skene_gland_origin_|Adenocarcinoma of Skene gland origin]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Adenosquamous_carcinoma_of_the_vagina|Adenosquamous carcinoma of the vagina]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Adenosarcoma_of_the_vagina_|Adenosarcoma of the vagina]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Germ_cell_tumours_of_the_vagina|Germ cell tumours of the vagina]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |CHAPTER 11 (TUMOURS OF THE VULVA) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | |- | ||
+ | |[[FEMA5:Seborrhoeic_keratosis|Seborrhoeic keratosis]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Condyloma_acuminatum|Condyloma acuminatum]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Squamous_intraepithelial_lesions,_HPV-associated,_of_the_vulva|Squamous intraepithelial lesions, HPV-associated, of the vulva]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Vulvar_intraepithelial_neoplasia,_HPV-independent|Vulvar intraepithelial neoplasia, HPV-independent]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Squamous_cell_carcinoma,_HPV-associated,_of_the_vulva|Squamous cell carcinoma, HPV-associated, of the vulva]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Squamous_cell_carcinoma,_HPV-independent,_of_the_vulva|Squamous cell carcinoma, HPV-independent, of the vulva]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Papillary_hidradenoma_|Papillary hidradenoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Chondroid_syringoma|Chondroid syringoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Fibroadenoma_|Fibroadenoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Phyllodes_tumour|Phyllodes tumour]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Adenocarcinoma_of_mammary_gland_type_|Adenocarcinoma of mammary gland type]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Bartholin_gland_cyst|Bartholin gland cyst]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Bartholin_gland_hyperplasia,_adenoma,_and_adenomyoma|Bartholin gland hyperplasia, adenoma, and adenomyoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Bartholin_gland_carcinomas|Bartholin gland carcinomas]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Other_cysts_of_the_vulva|Other cysts of the vulva]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Paget_disease_|Paget disease]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Carcinomas_of_sweat_gland_origin|Carcinomas of sweat gland origin]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Adenocarcinoma_of_intestinal_type_|Adenocarcinoma of intestinal type]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Germ_cell_tumours_of_the_vulva|Germ cell tumours of the vulva]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |CHAPTER 12 (NEUROENDOCRINE NEOPLASIA) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | |- | ||
+ | |[[FEMA5:Neuroendocrine_tumour|Neuroendocrine tumour]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Small_cell_neuroendocrine_carcinoma|Small cell neuroendocrine carcinoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Large_cell_neuroendocrine_carcinoma|Large cell neuroendocrine carcinoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Carcinoma_admixed_with_neuroendocrine_carcinoma_|Carcinoma admixed with neuroendocrine carcinoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |CHAPTER 13 (HAEMATOLYMPHOID PROLIFERATIONS AND NEOPLASIA) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | |- | ||
+ | |[[FEMA5:Florid_reactive_lymphoid_hyperplasia|Florid reactive lymphoid hyperplasia]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Diffuse_large_B-cell_lymphoma|Diffuse large B-cell lymphoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Extranodal_marginal_zone_lymphoma|Extranodal marginal zone lymphoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Follicular_lymphoma|Follicular lymphoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Burkitt_lymphoma|Burkitt lymphoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Myeloid_sarcoma|Myeloid sarcoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |CHAPTER 14 (MESENCHYMAL TUMOURS OF THE LOWER GENITAL TRACT) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | |- | ||
+ | |[[FEMA5:Lipoma_|Lipoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Lipoblastoma-like_tumour_of_the_vulva|Lipoblastoma-like tumour of the vulva]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Liposarcoma_|Liposarcoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Postoperative_spindle_cell_nodule|Postoperative spindle cell nodule]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Fibroepithelial_stromal_polyp|Fibroepithelial stromal polyp]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Prepubertal_fibroma|Prepubertal fibroma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Superficial_myofibroblastoma_|Superficial myofibroblastoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Myofibroblastoma_|Myofibroblastoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Cellular_angiofibroma_|Cellular angiofibroma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Angiomyofibroblastoma_|Angiomyofibroblastoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Solitary_fibrous_tumour_of_the_lower_genital_tract|Solitary fibrous tumour of the lower genital tract]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Dermatofibrosarcoma_protuberans_|Dermatofibrosarcoma protuberans]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:NTRK-rearranged_spindle_cell_neoplasm_(emerging)|NTRK-rearranged spindle cell neoplasm (emerging)]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Kaposi_sarcoma_|Kaposi sarcoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Angiosarcoma_|Angiosarcoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Leiomyoma_of_the_lower_genital_tract|Leiomyoma of the lower genital tract]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Smooth_muscle_tumour_of_uncertain_malignant_potential_of_the_lower_genital_tract|Smooth muscle tumour of uncertain malignant potential of the lower genital tract]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Leiomyosarcoma_of_the_lower_genital_tract|Leiomyosarcoma of the lower genital tract]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Rhabdomyoma_|Rhabdomyoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Rhabdomyosarcoma|Rhabdomyosarcoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Benign_peripheral_nerve_sheath_tumours|Benign peripheral nerve sheath tumours]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Granular_cell_tumour_|Granular cell tumour]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Superficial_angiomyxoma_|Superficial angiomyxoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Deep_(aggressive)_angiomyxoma_|Deep (aggressive) angiomyxoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Epithelioid_sarcoma_|Epithelioid sarcoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Alveolar_soft_part_sarcoma_|Alveolar soft part sarcoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Ewing_sarcoma_|Ewing sarcoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |CHAPTER 15 (MELANOCYTIC LESIONS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | |- | ||
+ | |[[FEMA5:Acquired_melanocytic_naevus|Acquired melanocytic naevus]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Congenital_melanocytic_naevus_|Congenital melanocytic naevus]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Blue_naevus_|Blue naevus]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Atypical_melanocytic_naevus_of_genital_type_|Atypical melanocytic naevus of genital type]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Dysplastic_melanocytic_naevus_|Dysplastic melanocytic naevus]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Mucosal_melanoma_|Mucosal melanoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |CHAPTER 16 (METASTASIS) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | |- | ||
+ | |[[FEMA5:Metastasis_to_the_lower_female_genital_tract|Metastasis to the lower female genital tract]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |CHAPTER 17 (GENETIC TUMOUR SYNDROMES OF THE FEMALE GENITAL TRACT) | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | | | ||
+ | ---- | ||
+ | |- | ||
+ | |[[FEMA5:BRCA1/2-associated_hereditary_breast_and_ovarian_cancer_syndrome|BRCA1/2-associated hereditary breast and ovarian cancer syndrome]] | ||
+ | |Disease | ||
+ | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |- | ||
+ | |[[FEMA5:Lynch_syndrome|Lynch syndrome]] | ||
+ | |Disease | ||
+ | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |- | ||
+ | |[[FEMA5:Cowden_syndrome|Cowden syndrome]] | ||
+ | |Disease | ||
+ | |[[DIG5:Volunteer Assignments and Opportunities|See DIG5 volunteer sheet for authorship status]] | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |- | ||
+ | |[[FEMA5:Li-Fraumeni_syndrome|Li-Fraumeni syndrome]] | ||
+ | |Disease | ||
+ | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |- | ||
+ | |[[FEMA5:Peutz-Jeghers_syndrome|Peutz-Jeghers syndrome]] | ||
+ | |Disease | ||
+ | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |- | ||
+ | |[[FEMA5:Ataxia-telangiectasia|Ataxia-telangiectasia]] | ||
+ | |Disease | ||
+ | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |- | ||
+ | |[[FEMA5:Carney_complex|Carney complex]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:DICER1_syndrome_|DICER1 syndrome]] | ||
+ | |Disease | ||
+ | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |- | ||
+ | |[[FEMA5:Ovarian_dysgenesis|Ovarian dysgenesis]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]] | ||
+ | |Disease | ||
+ | |[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]] | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |N/A | ||
+ | |- | ||
+ | |[[FEMA5:Hereditary_leiomyomatosis_and_renal_cell_carcinoma|Hereditary leiomyomatosis and renal cell carcinoma]] | ||
+ | |Disease | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | | | ||
+ | |- | ||
+ | |[[FEMA5:Other genetic tumour syndromes of the female genital tract|Other genetic tumour syndromes of the female genital tract]] | ||
|Disease | |Disease | ||
| | | |
Revision as of 16:42, 15 July 2024
Welcome!
For assignments, please see the "Author" column below (highlighted blue).
If empty (no name is present), please volunteer to create content for that disease!
To volunteer, please [Contact us] with your page of interest.